What is the official website of Sykehusapotekene HF ?

The official website of Sykehusapotekene HF is http://www.sykehusapotekene.no.

What is Sykehusapotekene HF's cybersecurity risk score?

Sykehusapotekene HF has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sykehusapotekene HF experienced?

According to Rankiteo, Sykehusapotekene HF currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sykehusapotekene HF been affected by any supply chain cyber incidents ?

According to Rankiteo, Sykehusapotekene HF has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sykehusapotekene HF have SOC 2 Type 1 certification ?

According to Rankiteo, Sykehusapotekene HF is not certified under SOC 2 Type 1.

Does Sykehusapotekene HF have SOC 2 Type 2 certification ?

According to Rankiteo, Sykehusapotekene HF does not hold a SOC 2 Type 2 certification.

Does Sykehusapotekene HF comply with GDPR ?

According to Rankiteo, Sykehusapotekene HF is not listed as GDPR compliant.

Does Sykehusapotekene HF have PCI DSS certification ?

According to Rankiteo, Sykehusapotekene HF does not currently maintain PCI DSS compliance.

Does Sykehusapotekene HF comply with HIPAA ?

According to Rankiteo, Sykehusapotekene HF is not compliant with HIPAA regulations.

Does Sykehusapotekene HF have ISO 27001 certification ?

According to Rankiteo,Sykehusapotekene HF is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sykehusapotekene HF operate in ?

Sykehusapotekene HF operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sykehusapotekene HF have ?

Sykehusapotekene HF employs approximately 448 people worldwide.

Does Sykehusapotekene HF own any subsidiaries ?

Sykehusapotekene HF presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sykehusapotekene HF have ?

Sykehusapotekene HF's official LinkedIn profile has approximately 2,514 followers.

What is the NAICS classification code for Sykehusapotekene HF ?

Sykehusapotekene HF is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sykehusapotekene HF have a Crunchbase profile ?

No, Sykehusapotekene HF does not have a profile on Crunchbase.

Does Sykehusapotekene HF have a LinkedIn profile ?

Yes, Sykehusapotekene HF maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sykehusapotekene-ans.

How many cybersecurity incidents has Sykehusapotekene HF experienced ?

As of October 4, 2026, Rankiteo reports that Sykehusapotekene HF has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Sykehusapotekene HF have ?

Sykehusapotekene HF has an estimated 5,772 peer or competitor companies worldwide.

What types of cybersecurity incidents has Sykehusapotekene HF faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sykehusapotekene HF

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

Sykehusapotekene HF Vendor Cyber Rating & Cyber Score

sykehusapotekene.no

Add Your Compliance Badge

Dette er en side om Sykehusapotekene HF. Mer informasjon finner du på våre internettsider: www.sykehusapotekene.no

Sykehusapotekene HF

Sykehusapotekene HF CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Sykehusapotekene HF

Breach

100

10/2025

HEL101191010282...

Sykehusapotekene HF

Breach

100

01/2018

HEL448181223

Loading…

A.I.

Sykehusapotekene HF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sykehusapotekene HF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sykehusapotekene HF in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sykehusapotekene HF in 2026.

Incident Types Sykehusapotekene HF vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sykehusapotekene HF in 2026.

Incident History - Sykehusapotekene HF (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sykehusapotekene HF Subsidiaries

Sykehusapotekene HF

Pharmaceutical Manufacturing

Website: http://www.sykehusapotekene.no

Company Size: 448

Helse Sør-Øst RHFHospitals and Health Care

Oslo University HospitalHospitals and Health Care

Institute for Cancer Genetics and Informatics, Oslo University HospitalResearch Services

Colorectal Cancer Research NetworkBiotechnology Research

Vestre Viken HFHospitals and Health Care

Sykehuset ØstfoldHospitals and Health Care

Akershus universitetssykehusHospitals and Health Care

Sykehuset InnlandetHospitals and Health Care

Sunnaas sykehus HFHospitals and Health Care

Sykehuspartner HFHospitals and Health Care

Vestfold Hospital TrustHospitals and Health Care

Telemark Hospital TrustHospitals and Health Care

Sørlandet sykehus HFHospitals and Health Care

Loading…

Sykehusapotekene HF Similar Companies

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Sykehusapotekene HF CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96451

SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/ultimate-member/vulnerability/wordpress-ultimate-member-plugin-2-13-1-privilege-escalation-vulnerability?_s_id=cve

CVE-2026-103342

SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/unlimited-elements-for-elementor/vulnerability/wordpress-unlimited-elements-for-elementor-free-widgets-addons-templates-plugin-2-0-20-cross-site-scripting-xss-vulnerability?_s_id=cve

CVE-2026-103065

SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N

Impact Score

4.2

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/kirki/vulnerability/wordpress-kirki-plugin-6-3-1-arbitrary-code-execution-vulnerability?_s_id=cve

CVE-2026-105122

SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-105121

SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Sykehusapotekene HF Vendor Cyber Rating & Cyber Score

Sykehusapotekene HF A.I CyberSecurity Scoring

Sykehusapotekene HF CyberSecurity News & History

Sykehusapotekene HF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sykehusapotekene HF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sykehusapotekene HF vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sykehusapotekene HF (X = Date, Y = Severity)

Sykehusapotekene HF Subsidiaries

Sykehusapotekene HF

Sykehusapotekene HF Similar Companies

Takeda

Novo Nordisk

Grifols

AbbVie

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Johnson & Johnson Innovative Medicine

Catalent

Servier

Sykehusapotekene HF CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Sykehusapotekene HF CyberSecurity News & History

Sykehusapotekene HF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sykehusapotekene HF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sykehusapotekene HF vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sykehusapotekene HF (X = Date, Y = Severity)

Sykehusapotekene HF Subsidiaries

Sykehusapotekene HF

Sykehusapotekene HF Similar Companies

Takeda

Novo Nordisk

Grifols

AbbVie

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Johnson & Johnson Innovative Medicine

Catalent

Servier

Sykehusapotekene HF CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo